Indivior PLC

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.

SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Indivior PLC (NASDAQ: INDV) securities between February 22, 2024 and July 8, 2024. Indivior is a global pharmaceutical company that develops, manufactures, and markets drugs to treat opioid use disorders (“OUD”) and serious mental illnesses.

Shareholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Indivior PLC (INDV)

NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Indivior PLC (NASDAQ: INDV).

Investors who lost money on Indivior PLC (INDV) should contact The Gross Law Firm about pending Class Action - INDV

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Indivior PLC (INDV) Investors.

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Indivior PLC (INDV) Investors

NEW YORK CITY, NY / ACCESSWIRE / August 7, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Indivior securities between February 22, 2024, and July 8, 2024, inclusive (the "Class Period").

INDV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Indivior PLC Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Indivior PLC (“Indivior” or the “Company”) (NASDAQ: INDV) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Indivior investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws,.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Indivior PLC (INDV) on Behalf of Investors

NEW YORK CITY, NY / ACCESSWIRE / August 6, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Indivior securities between February 22, 2024, and July 8, 2024, inclusive (the "Class Period").

INDV INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Indivior PLC Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Indivior PLC (“Indivior” or the “Company”) (NASDAQ: INDV) investors concerning the Company's possible violations of federal securities laws. On July 9, 2024, Indivior disclosed that it would be immediately ceasing all sales and marketing activities related to its schizophrenia treatment, PERSERIS due to the highly competitive market “and impending changes that are expected to intensify payor m.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Indivior PLC (INDV) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Indivior PLC (“Indivior” or the “Company”) (NASDAQ: INDV) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On July 9, 2024, Indivior disclosed that it would be immediately ceasing all sales and marketing activities related to its schizophrenia treatment, PERSERIS due to the highly comp.

The Law Offices of Frank R. Cruz Announces Investigation of Indivior PLC (INDV) on Behalf of Investors

NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Indivior PLC (“Indivior”) (NASDAQ: INDV) between February 22, 2024 and July 8, 2024, inclusive (the “Class Period”). For more information, submit a form at Indivior PLC Shareholder Class Action Lawsuit, email Investor Relations Manager Peter Allocco at pallocco@bernlieb.com, or call us at (212) 951-2030.

INDIVIOR PLC (NASDAQ: INDV) INVESTOR ALERT: Investors With Large Losses in Indivior PLC Should Contact Bernstein Liebhard LLP To Discuss Their Rights

NEW YORK, NY / ACCESSWIRE / August 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Indivior PLC ("Indivior") (NASDAQ:INDV) concerning possible violations of federal securities laws. On July 9, 2024, Indivior issued a press release announcing "a business update encompassing [its] for Q2 and FY 2024 financial performance[.

Indivior PLC INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Indivior (INDV)

Shareholder Rights Advocates at Levi & Korsinsky Investigate Indivior PLC (INDV) Regarding Possible Securities Fraud Violations

ATLANTA, Aug. 05, 2024 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Indivior PLC (“Indivior,” or the “Company”) (NASDAQ: INDV). The lawsuit alleges that Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects, including allegations that Defendants: (i) grossly overstated their ability to forecast the negative impact of certain legislation on the financial prospects of Indivior products, which forecasting ability was far less capable and effective than Defendants had led investors and analysts to believe; (ii) overstated the financial prospects of SUBLOCADE, PERSERIS and OPVEE, and thus overstated the Company's anticipated revenue and other financial metrics; (iii) knew or recklessly disregarded that because of the negative impact of certain legislation on the financial prospects of Indivior's products, Indivior was unlikely to meet its own previously issued and repeatedly reaffirmed FY 2024 net revenue guidance, including its FY 2024 net revenue guidance for SUBLOCADE, PERSERIS and OPVEE; and (iv) knew or recklessly disregarded that Indivior was at a significant risk of, and/or was likely to, cease all sales and marketing activities related to PERSERIS.

SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Indivior PLC (INDV) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

Indivior Being Investigated on Behalf of Indivior PLC Investors. Contact Levi & Korsinsky For Details

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Indivior PLC (INDV)

NEW YORK, NY / ACCESSWIRE / August 3, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Indivior PLC ("Indivior") (NASDAQ:INDV) concerning possible violations of federal securities laws. On July 9, 2024, Indivior issued a press release announcing "a business update encompassing [its] for Q2 and FY 2024 financial performance[.

Levi & Korsinsky Announces an Investigation on Behalf of Indivior PLC (INDV) Shareholders Who May Have Been Affected by Fraud

NEW YORK, Aug. 03, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Indivior PLC (“Indivior” or the “Company”) (NASDAQ: INDV).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com  or 646-581-9980, ext. 7980.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Indivior PLC - INDV

NEW YORK , Aug. 2, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Indivior PLC ("Indivior" or the "Company") (NASDAQ: INDV) and certain officers. The class action, filed in the United States District Court for the Eastern District of Virginia (Richmond Division), and docketed under 24-cv-00554, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Indivior securities between February 22, 2024 and July 8, 2024, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officers.

Pomerantz Law Firm Announces the Filing of a Class Action Against Indivior PLC and Certain Officers - INDV

NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Indivior PLC ("Indivior") (NASDAQ:INDV) concerning possible violations of federal securities laws. On July 9, 2024, Indivior issued a press release announcing "a business update encompassing [its] for Q2 and FY 2024 financial performance[.

INDV STOCK ALERT: Levi & Korsinsky Notifies Indivior PLC Investors of an Ongoing Investigation

NEW YORK , Aug. 1, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Indivior PLC ("Indivior" or the "Company") (NASDAQ: INDV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Indivior PLC - INDV

NEW YORK, NY / ACCESSWIRE / July 31, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Indivior PLC ("Indivior") (NASDAQ:INDV) concerning possible violations of federal securities laws. On July 9, 2024, Indivior issued a press release announcing "a business update encompassing [its] for Q2 and FY 2024 financial performance[.

An Investigation Has Commenced on Behalf of Indivior PLC Shareholders. Contact Levi & Korsinsky to Discuss your INDV Losses

Indivior reached an $86 million settlement to resolve the company's role in spreading opioid addiction across the United States, New York Attorney General Letitia James said on Friday.

Indivior reaches $86 million opioid settlement with US states

Indivior stock price increased by a massive 20% after its Q2 2024 earnings release. Even though nothing unexpected is in the results, progress on its legal challenges is a positive. The company now expects settlement for opioid treatments' related litigation that has dragged on for years, news that's supported by an uptick in revenues and adjusted earnings. While Indivior saw losses in reported terms due to multiple exceptional costs, its market multiples look attractive on a non-GAAP basis.

Indivior: End Of Legal Challenges In Sight

Indivior PLC (NASDAQ:INDV ) Q2 2024 Earnings Conference Call July 25, 2024 8:30 AM ET Company Participants Jason Thompson - VP, IR Mark Crossley - CEO Christian Heidbreder - Chief Scientific Officer Ryan Preblick - CFO Conference Call Participants David Amsellem - Piper Sandler Paul Cudden - Deutsche Numis Chase Knickerbocker - Craig-Hallum Thibault Boutherin - Morgan Stanley Max Herrmann - Stifel Operator Good day, and thank you for standing by. Welcome to the Indivior PLC Half Year Results 2024 Conference Call and Webcast.

Indivior PLC (INDV) Q2 2024 Earnings Call Transcript

Indivior PLC (INDV) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.40 per share. This compares to earnings of $0.39 per share a year ago.

Indivior PLC (INDV) Q2 Earnings and Revenues Beat Estimates

NEW YORK CITY, NY / ACCESSWIRE / July 25, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV). Investors who purchased Indivior securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/INDV.

News for Indivior PLC Stock (INDV)